TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company ...

For example, 2024’s biopharma IPO market began promisingly with $3.6 billion in total funding in Q1 – the highest in several years – but fell to $1.6 billion across Q2 and Q3 combined ...

Life-changing interventions that have previously been pipedreams are now within reach for the biopharma industry, made possible through an increasingly sophisticated understanding of human biology ...

Healthcare & Pharmaceuticalscategory· March 26, 2025 Bayer acquires rights in Puhe BioPharma cancer drug candidate Bayer said on Wednesday it struck a global licence agreement for an experimental ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

In late 1890, Daniel Burnham, the eminent architect charged with turning a boggy square mile of Chicago into a world-dazzling showpiece, assembled an all-star team of designers and gave them one ...

Sheilas' Wheels entered the car insurance market in 2005, with policies primarily aimed at female drivers. However, it now sells to all drivers. It's part of the Esure group, along with insurance ...

Researching and developing therapeutic products for human use.

The new bid surpasses an offer SK Capital and Carlyle Group made last month for the gene therapy developer, which Bluebird’s board still supports.